Article Figures & Data
Figures
Johannes Czernin
Jeremie Calais
Tables
Molecular radiotherapy agent Patients per year Cycles per year 177Lu-DOTATATE 7,500 30,000 (4 cycles per patient) 177Lu-PSMA 34,000 120,000 (2–6 cycles) Total 41,500 150,000 - TABLE 2
How Many Centers Are Needed in United States to Deliver 150,000 Treatment Cycles per Year?
Cycles per site per day Cycles per site per year Centers needed to deliver 150,000 cycles per year* 8 2,088 70 4 1,044 140 2 522 280 *Approximations.
In this issue
Jump to section
Related Articles
Cited By...
- Reflections on the Demand for PSMA- and SSTR-Targeted Radiopharmaceutical Therapies: Why We Were Wrong (and Why We Will Be Right Eventually)
- 177Lu-PSMA (R)Evolution in Cancer Care: Is It Really Happening?
- Differences and Common Ground in 177Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers
- Tackling the Last Mile: A Major Component to Successfully Establish Radioligand Therapy